News

November 1, 2017November 1, 2017

Higher Rate of Infections in JIA Patients Who Take Biologic Therapies, Study Finds

News

Patients with juvenile idiopathic arthritis (JIA) who take biologic therapies have a higher rate of serious or opportunistic infections, a new study shows. The study reporting that finding, “High rate ... Read more

October 18, 2017October 18, 2017

Physical Activity in JIA Patients Deteriorates with Time, Long-term Study Finds

News

Patients with juvenile idiopathic arthritis undergo a significant deterioration in physical health-related quality of life over time, a 30-year follow-up study shows. The study “Physical Functioning, Pain and Health-Related Quality of Life in Adults with Juvenile Idiopathic Arthritis: ... Read more

October 4, 2017October 4, 2017

Disease Duration, Category May Help Predict Response to Enbrel in Juvenile Idiopathic Arthritis Patients

News

The category and duration of disease in juvenile idiopathic arthritis (JIA) could help predict whether treatment with Enbrel (etanercept) in patients without systemic manifestations will be effective, a new study from ... Read more

September 29, 2017September 29, 2017

IMIDBio-UK Consortium Plans World’s Largest Inflammatory Disease Biobank

News

The IMIDBio-UK consortium — funded by a £1.7 million ($2.3 million) grant from the Medical Research Council (MRC) — will bring together samples and clinical data from more than 40,000 ... Read more

September 22, 2017September 22, 2017

Systemic Arthritis and Prolonged Corticosteroid Use Associated with Growth Impairment in Juvenile Idiopathic Arthritis

News

A recent study showed that children with juvenile idiopathic arthritis (JIA) now have similar growth and weight gain as children in the general population. Nonetheless, about 1 in 10 JIA children ... Read more

September 20, 2017September 20, 2017

Boehringer Ingelheim’s Cyltezo Receives Positive European CHMP Opinion for Chronic Inflammatory Diseases

News

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended the use of Boehringer Ingelheim’s Cyltezo, an adalimumab biosimilar, for the treatment of ... Read more

September 15, 2017September 15, 2017

Arthritis Patients Find It Hard to Explain Invisible Symptoms, Survey Shows

News

Health Union’s latest survey found that more than eight in 10 people (85%) diagnosed with a form of arthritis say it is difficult to explain their “invisible” symptoms to others. The survey, ... Read more

September 13, 2017September 13, 2017

Hap & Harry’s and Kings of Leon Partner on Revelry Ale to Raise Funds for Arthritis Foundation

News

Hap & Harry’s Tennessee Beer is collaborating with the Grammy award-winning band Kings of Leon to produce a limited-edition release called Revelry amber ale, to raise funds for the Arthritis Foundation and ... Read more

September 8, 2017September 8, 2017

Advanced DNA Sequencing Techniques Reveal New Clues on What Triggers JIA, Study Shows

News

New insights gained from DNA sequencing techniques about genetic changes associated with the development of juvenile idiopathic arthritis (JIA) provide new clues into the mechanisms underlying this disease and may ... Read more

September 6, 2017September 6, 2017

Arthritis Foundation Grant Funding a Study on Interplay Between Genes and Environment in Juvenile Arthritis

News

A University at Buffalo pediatric professor has received a $731,000 Arthritis Foundation grant to study the interplay between genes and the environment that leads to immune dysfunction in patients with juvenile arthritis. ... Read more